Boehringer’s Nerandomilast Hits Primary Endpoint in Phase III FIBRONEER-ILD for Pulmonary Fibrosis Read more
Novartis Strengthens Cardiovascular Pipeline with $925 Million Anthos Therapeutics Acquisition Read more
Imfinzi Recommended for EU Approval as First Immunotherapy for Limited-Stage Small Cell Lung Cancer Read more
Sarclisa Approved in China as First Anti-CD38 Treatment for Newly Diagnosed Multiple Myeloma Read more
FDA Grants Priority Review to Merck’s WELIREG for Advanced Pheochromocytoma and Paraganglioma Read more